- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Chinese refractory or relapsed SAA subjects
Total 225367 results
-
Arog Pharmaceuticals, Inc.CompletedPhase II Study of Crenolanib in Subjects With Relapsed/Refractory AML With FLT3 Activating MutationsRelapsed or Refractory Acute Myeloid Leukemia With FLT3 Activating MutationsUnited States
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited Kingdom, Poland
-
AmgenTerminatedRelapsed and/or Refractory Multiple MyelomaUnited States, Japan, Belgium, Australia, Switzerland
-
Novartis PharmaceuticalsCompletedImmune Thrombocytopenic Purpura (ITP)Spain, Italy, Greece, Switzerland, United Kingdom, France, Turkey, Russian Federation, Brazil, Austria, Mexico, Oman, Chile, Japan, United States
-
pharmaand GmbHCompletedMultiple MyelomaCanada, Spain, United States, Czechia, Turkey, France, Sweden, Korea, Republic of, Thailand, Belgium, Greece, Germany, Hungary, Russian Federation, Italy, Poland, Australia, Lebanon, Portugal, Norway, Brazil, Netherlands
-
Institute of Hematology & Blood Diseases Hospital...Nanjing Legend Biotech Co.TerminatedAcute Myeloid LeukemiaChina
-
Elucida OncologyTherapeutic Advances in Childhood Leukemia and Lymphoma (TACL)WithdrawnAcute Myeloid Leukemia | AML, Childhood | Relapsed Pediatric AML | Refractory Pediatric AML
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Italy, Austria, Canada, France, Germany, Japan, Spain, Sweden, United Kingdom
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.TerminatedRelapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChina
-
Vincerx Pharma, Inc.TerminatedChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Relapsed Non Hodgkin Lymphoma | Richter Syndrome | MYC Amplification | MYC Overexpression | MYC TranslocationUnited States, Poland
-
Kite, A Gilead CompanyCompletedRelapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaUnited States, France, Germany, Netherlands, Canada
-
CelgeneCompletedLymphoma, Non-HodgkinUnited States, Belgium, Germany, Japan, Netherlands, France, Sweden, Italy, Spain, Switzerland, United Kingdom, Finland
-
IGM Biosciences, Inc.ADC Therapeutics S.A.Active, not recruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | DLBCLUnited States, Korea, Republic of, Spain, France, Australia, Czechia, Italy
-
OncotherapeuticsTakedaCompletedMultiple MyelomaUnited States
-
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Completed
-
BeBetter Med IncCompletedRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Non-Hodgkin's LymphomaChina
-
AmgenTerminatedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Japan, Germany, Netherlands, Canada
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Denmark, Australia, Belgium, Finland, Greece, Japan, Korea, Republic of, Spain, United Kingdom
-
CelgeneActive, not recruitingLymphomaUnited States, France, Germany, Italy, Korea, Republic of, Taiwan
-
Legend Biotech USA IncActive, not recruitingT-Cell Lymphoma | Peripheral T-Cell Lymphoma Refractory | Cutaneous T-Cell Lymphoma Refractory | Cutaneous T-Cell Lymphoma Recurrent | Peripheral T-Cell Lymphoma RecurrentUnited States
-
HitGen Inc.TerminatedMultiple Myeloma | Relapsed and Refractory Multiple MyelomaChina
-
GenmabAbbVieTerminatedFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Small Lymphocytic Lymphoma | High-grade B-cell Lymphoma | Primary Mediastinal Large B-cell LymphomaUnited States, Spain, Netherlands, Belgium, France, Denmark
-
SanofiCompleted
-
CRISPR Therapeutics AGActive, not recruitingMultiple MyelomaUnited States, Spain, Australia, Canada
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Ukraine, United Kingdom
-
Shanghai Vinnerna Biosciences Co., Ltd.Active, not recruitingThe Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese SubjectsChina
-
Kartos Therapeutics, Inc.TerminatedSmall Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer RecurrentGermany, Spain, France, Australia, United States, Korea, Republic of, Hungary
-
Kyowa Kirin Co., Ltd.Active, not recruitingStudy of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)Indolent B-cell Non-Hodgkin's LymphomaJapan
-
Actinium PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia | Leukemia, Myeloid, Acute | AML | Acute Myelogenous Leukemia | Bone Marrow Transplant | Myelogenous Leukemia, Acute | Myeloid Leukemia, Acute | Leukemia, Acute Myelogenous | Leukemia, Acute MyeloidUnited States, Canada
-
Weijia Fang, MDNanjing Blue Shield Biotech Co.,LtdCompleted
-
Telios Pharma, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Relapsed/Refractory B Cell Malignancies | Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma | Treatment-Naive B Cell MalignanciesUnited States, Poland, Ukraine, Hungary, Italy, Russian Federation, United Kingdom
-
Astex Pharmaceuticals, Inc.TerminatedAcute Myeloid Leukemia | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmUnited States, Canada
-
University of PennsylvaniaCompletedPatients With B Cell ALL, Relapsed or Refractory, With no Available Curative Treatment OptionsUnited States
-
Incyte CorporationCompleted
-
CStone PharmaceuticalsCompletedExtranodal Natural Killer/T-Cell LymphomaUnited States, China
-
CelgeneCompletedMultiple MyelomaUnited States, Spain, United Kingdom, Italy, Israel, Portugal, Germany, Turkey, Greece, Ireland, Austria, Norway, Netherlands, Denmark, Poland, France, Russian Federation, Canada, Finland, Japan, Puerto Rico, Sweden
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Japan, Puerto Rico
-
AbbVieCelgene; Genentech, Inc.CompletedMyelodysplastic Syndromes (MDS)United States, Australia, Germany
-
Kyowa Kirin Co., Ltd.Active, not recruitingRelapsed or Refractory Indolent B-cell Non-Hodgkin's LymphomaJapan
-
AmgenTerminatedAcute Myeloid Leukemia | Multiple Myeloma | AML | Myelodysplastic Syndrome | MDS | Non-Hodgkins Lymphoma | NHLUnited States, Australia, Italy, France, Greece, Japan
-
PfizerTerminatedMelanoma | Soft Tissue Sarcoma | Mycosis Fungoides | Breast Carcinoma | Solid Tumors | Squamous Cell Carcinoma | Human Papillomavirus-Related Malignant Neoplasm | Merkel-cell CarcinomaUnited States
-
Antengene CorporationActive, not recruitingRelapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)China
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinCanada, Spain, United States, Austria
-
Hoffmann-La RocheTerminated
-
AbbVieCompletedChronic Lymphocytic Leukemia (CLL)Argentina, Australia, Bulgaria, Hong Kong, Hungary, Mexico, New Zealand, Poland, Russian Federation, Taiwan
-
CelgeneCompletedLymphoma, Non-HodgkinUnited States, Spain, China, Belgium, France, United Kingdom, Israel, Turkey, Russian Federation, Italy, Brazil, Czechia, Portugal, Germany, Japan, Poland, Puerto Rico
-
AmgenCompleted
-
Precision BioSciences, Inc.CompletedLymphoma, Non-Hodgkin | Chronic Lymphocytic Leukemia | B-cell Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | B-cell Non Hodgkin Lymphoma | Leukemia, Lymphocytic, Chronic | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Chronic Lymphoid Leukemia in RelapseUnited States
-
Peking Union Medical College HospitalCompletedDrug Effect | Aplastic AnemiaChina